|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 545.40 SEK | -4.28% |
|
-5.28% | +5.86% |
| 05/06 | Stockholm stocks end week lower, OMXS30 index sheds 0.6 percent | FW |
| 05/06 | Morgan Stanley raises Boliden price target to SEK 513 (493), reiterates Equal-weight - BN | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 6.86TCr | 8.64TCr | 7.86TCr | 8.92TCr | 9.35TCr | |||||
Total Revenues | 6.86TCr | 8.64TCr | 7.86TCr | 8.92TCr | 9.35TCr | |||||
Cost of Goods Sold, Total | 5.57TCr | 6.83TCr | 6.78TCr | 7.63TCr | 7.77TCr | |||||
Gross Profit | 1.29TCr | 1.81TCr | 1.07TCr | 1.29TCr | 1.58TCr | |||||
Selling General & Admin Expenses, Total | 114.9Cr | 168.3Cr | 184.1Cr | 204.1Cr | 195.8Cr | |||||
R&D Expenses | 96Cr | 104.8Cr | 115.1Cr | 113.6Cr | 129.2Cr | |||||
Other Operating Expenses | 8.3Cr | 6.4Cr | -40Cr | -8.1Cr | -4.7Cr | |||||
Other Operating Expenses, Total | 219.7Cr | 279.5Cr | 258.9Cr | 309.6Cr | 320.3Cr | |||||
Operating Income | 1.07TCr | 1.54TCr | 814.8Cr | 980.6Cr | 1.26TCr | |||||
Interest Expense, Total | -12Cr | -25Cr | -69Cr | -95Cr | -109.2Cr | |||||
Interest And Investment Income | 10L | 4.9Cr | 20Cr | 22Cr | 16Cr | |||||
Net Interest Expenses | -12Cr | -20Cr | -49Cr | -74Cr | -93Cr | |||||
Income (Loss) On Equity Invest. | - | - | -10L | - | 40L | |||||
Currency Exchange Gains (Loss) | 21Cr | 44Cr | - | 26Cr | 24Cr | |||||
Other Non Operating Income (Expenses) | -1.3Cr | -2.4Cr | -5.8Cr | -11Cr | -7.6Cr | |||||
EBT, Excl. Unusual Items | 1.08TCr | 1.56TCr | 760Cr | 921.6Cr | 1.18TCr | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 60L | - | - | - | 1.9Cr | |||||
Insurance Settlements | 60L | 2Cr | - | 333.9Cr | 6.5Cr | |||||
Other Unusual Items | 1.6Cr | 1.9Cr | - | - | - | |||||
EBT, Incl. Unusual Items | 1.08TCr | 1.56TCr | 760Cr | 1.26TCr | 1.19TCr | |||||
Income Tax Expense | 213.5Cr | 319.1Cr | 152.6Cr | 252.9Cr | 249.2Cr | |||||
Earnings From Continuing Operations | 870.5Cr | 1.24TCr | 607.4Cr | 1TCr | 940.9Cr | |||||
Net Income to Company | 870.5Cr | 1.24TCr | 607.4Cr | 1TCr | 940.9Cr | |||||
Minority Interest | -40L | -10L | -10L | -40L | -50L | |||||
Net Income - (IS) | 870.1Cr | 1.24TCr | 607.3Cr | 1TCr | 940.4Cr | |||||
Net Income to Common Incl Extra Items | 870.1Cr | 1.24TCr | 607.3Cr | 1TCr | 940.4Cr | |||||
Net Income to Common Excl. Extra Items | 870.1Cr | 1.24TCr | 607.3Cr | 1TCr | 940.4Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 31.81 | 45.37 | 22.2 | 36.65 | 33.39 | |||||
Basic EPS - Continuing Operations | 31.81 | 45.37 | 22.2 | 36.65 | 33.39 | |||||
Basic Weighted Average Shares Outstanding | 27Cr | 27Cr | 27Cr | 27Cr | 28Cr | |||||
Net EPS - Diluted | 31.81 | 45.37 | 22.2 | 36.65 | 33.39 | |||||
Diluted EPS - Continuing Operations | 31.81 | 45.37 | 22.2 | 36.65 | 33.39 | |||||
Diluted Weighted Average Shares Outstanding | 27Cr | 27Cr | 27Cr | 27Cr | 28Cr | |||||
Normalized Basic EPS | 24.69 | 35.56 | 17.36 | 21.05 | 26.21 | |||||
Normalized Diluted EPS | 24.69 | 35.56 | 17.36 | 21.05 | 26.21 | |||||
Dividend Per Share | 10.5 | 15 | 7.5 | - | 11 | |||||
Payout Ratio | 44.8 | 23.14 | 67.56 | 20.46 | - | |||||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.63TCr | 2.14TCr | 1.43TCr | 1.64TCr | 2.12TCr | |||||
EBITA | 1.07TCr | 1.54TCr | 816.5Cr | 982.3Cr | 1.26TCr | |||||
EBIT | 1.07TCr | 1.54TCr | 814.8Cr | 980.6Cr | 1.26TCr | |||||
EBITDAR | 1.68TCr | 2.22TCr | 1.54TCr | 1.76TCr | 2.23TCr | |||||
Effective Tax Rate - (Ratio) | 19.7 | 20.45 | 20.08 | 20.14 | 20.94 | |||||
Total Current Taxes | 215.2Cr | 324.2Cr | 147.5Cr | 177.1Cr | 219.6Cr | |||||
Total Deferred Taxes | -1.8Cr | -5.1Cr | 5.1Cr | 76Cr | 30Cr | |||||
Normalized Net Income | 675.35Cr | 972.59Cr | 474.9Cr | 575.6Cr | 738.06Cr | |||||
Interest on Long-Term Debt | 30L | 40L | 30L | 60L | 70L | |||||
Non-Cash Pension Expense | 1.2Cr | 70L | 1.7Cr | 2.4Cr | 2.8Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 52Cr | 65Cr | 73Cr | 76Cr | 62Cr | |||||
General and Administrative Expenses | 62Cr | 101.3Cr | 107.9Cr | 125.6Cr | 130.5Cr | |||||
Research And Development Expense From Footnotes | 98Cr | 106.9Cr | 117.9Cr | 117.5Cr | 133.6Cr | |||||
Net Rental Expense, Total | 56Cr | 84Cr | 113.3Cr | 115Cr | 111.7Cr | |||||
Imputed Operating Lease Interest Expense | 8.62Cr | 19Cr | 49Cr | 56Cr | 48Cr | |||||
Imputed Operating Lease Depreciation | 48Cr | 64Cr | 65Cr | 59Cr | 63Cr |
- Stock Market
- Equities
- BOL Stock
- Financials Boliden AB
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















